A phase 3 study to determine the breast cancer risk reducing effect of denosumab in women carrying a germline BRCA1 mutation (BRCA-P Study).

被引：0

作者：

Bhulani, Nizar

Wood, Marie

Tsai, Joy

Bedrosian, Isabelle

Hopkins, Judith O.

Brunet, Joan

Michaelson-Cohen, Rachel

Schmutzler, Rita K.

Evans, Gareth D.

Gnant, Michael

Fesl, Christian

Mystek, Aleksandra

Lindeman, Geoffrey J.

Singer, Christian F.

Garber, Judy Ellen

机构：

[1] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA USA

[2] Univ Colorado, Aurora, CO USA

[3] Massachusetts Gen Hosp, Boston, MA USA

[4] Univ Texas MD Anderson Canc Ctr, Houston, TX USA

[5] Novant Hlth, Forsyth Med Canc Inst, Southeast Clin Oncol Res Consortium, Kernersville, NC USA

[6] NCORP, Kernersville, NC USA

[7] Catalan Inst Oncol, Med Oncol, Girona, Spain

[8] Girona Biomed Res Inst IDIBGi, Girona, Spain

[9] Shaare Zedek Med Ctr, Jerusalem, Israel

[10] Univ Hosp Cologne, Ctr Familial Breast & Ovarian Canc, Med Fac, Cologne, Germany

[11] Univ Hosp Cologne, Med Fac, Ctr Integrated Oncol CIO, Cologne, Germany

[12] Univ Manchester, Manchester, Lancs, England

[13] Med Univ Vienna, Comprehens Canc Ctr, Vienna, Austria

[14] Austrian Breast & Colorectal Canc Study Grp, Vienna, Austria

[15] ABCSG, Vienna, Austria

[16] Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia

[17] Med Univ Vienna, Dept Obstet & Gynecol, Comprehens Canc Ctr, Vienna, Austria

[18] Med Univ Vienna, Ctr Breast Hlth, Comprehens Canc Ctr, Vienna, Austria

[19] Harvard Med Sch, Dana Farber Canc Inst, Canc Genet & Prevent, Boston, MA USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

TPS10616

引用

页数：1

共 50 条

[1] A phase III study to determine the breast cancer risk-reducing effect of denosumab in women carrying a pathogenic germline BRCA1 variant (The BRCA-P Study)
Michaelson-Cohen, Rachel
Brunet, Joan
Schmutzler, Rita Katharina
Evans, D. Gareth
Gnant, Michael
Hlauschek, Dominik
Mystek, Aleksandra
Bhulani, Nizar
Lindeman, Geoff
Singer, Christian
Garber, Judy
EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 544 - 545
[2] Parental origin of mutation and the risk of breast cancer in a prospective study of women with a BRCA1 or BRCA2 mutation
Senst, N.
Llacuachaqui, M.
Lubinski, J.
Lynch, H.
Armel, S.
Neuhausen, S.
Ghadirian, P.
Sun, P.
Narod, S. A.
CLINICAL GENETICS, 2013, 84 (01) : 43 - 46
[3] Breast cancer risk for Korean women with germline mutations in BRCA1 and BRCA2
Boyoung Park
James G. Dowty
Choonghyun Ahn
Aung K. Win
Sung-Won Kim
Min Hyuk Lee
Jong Won Lee
Eunyoung Kang
John L. Hopper
Sue K. Park
Breast Cancer Research and Treatment, 2015, 152 : 659 - 665
[4] Breast cancer risk for Korean women with germline mutations in BRCA1 and BRCA2
Park, Boyoung
Dowty, James G.
Ahn, Choonghyun
Win, Aung K.
Kim, Sung-Won
Lee, Min Hyuk
Lee, Jong Won
Kang, Eunyoung
Hopper, John L.
Park, Sue K.
BREAST CANCER RESEARCH AND TREATMENT, 2015, 152 (03) : 659 - 665
[5] Gastric atrophy in breast and ovarian cancer patients carrying BRCA1 germline mutation
Ivantsov, A. O.
Kleshchov, M. A.
Avariesyan, A. A.
Shelekhova, K.
Shcherbakov, A. M.
Linyanitov, F. N.
Sokolenko, A. P.
VIRCHOWS ARCHIV, 2016, 469 : S156 - S156
[6] Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutation
Kotsopoulos, Joanne
Gronwald, Jacek
Huzarski, Tomasz
Aeilts, Amber
Armel, Susan Randall
Karlan, Beth
Singer, Christian
Eisen, Andrea
Tung, Nadine
Olopade, Olufunmilayo
Bordeleau, Louise
Eng, Charis
Foulkes, William
Neuhausen, Susan
Cullinane, Carey
Pal, Tuya
Fruscio, Robert
Lubinski, Jan
Metcalfe, Kelly
Sun, Ping
Narod, Steven
BREAST CANCER RESEARCH AND TREATMENT, 2023, 201 (02) : 257 - 264
[7] Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutation
Joanne Kotsopoulos
Jacek Gronwald
Tomasz Huzarski
Amber Aeilts
Susan Randall Armel
Beth Karlan
Christian F. Singer
Andrea Eisen
Nadine Tung
Olufunmilayo Olopade
Louise Bordeleau
Charis Eng
William D. Foulkes
Susan L. Neuhausen
Carey A. Cullinane
Tuya Pal
Robert Fruscio
Jan Lubinski
Kelly Metcalfe
Ping Sun
Steven A. Narod
Breast Cancer Research and Treatment, 2023, 201 : 257 - 264
[8] Risk factor of the contralateral breast carcinoma in BRCA1 and BRCA2 in women carrying mutation
Graeser, M. K.
Engel, C.
Schmutzler, R. K.
GEBURTSHILFE UND FRAUENHEILKUNDE, 2008, 68 : S9 - S9
[9] Obesity promotes breast epithelium DNA damage in women carrying a germline mutation in BRCA1 or BRCA2
Bhardwaj, Priya
Iyengar, Neil M.
Zahid, Heba
Carter, Katharine M.
Byun, Dong Jun
Choi, Man Ho
Sun, Qi
Savenkov, Oleksandr
Louka, Charalambia
Liu, Catherine
Piloco, Phoebe
Acosta, Monica
Bareja, Rohan
Elemento, Olivier
Foronda, Miguel
Dow, Lukas E.
Oshchepkova, Sofya
Giri, Dilip D.
Pollak, Michael
Zhou, Xi Kathy
Hopkins, Benjamin D.
Laughney, Ashley M.
Frey, Melissa K.
Ellenson, Lora Hedrick
Morrow, Monica
Spector, Jason A.
Cantley, Lewis C.
Brown, Kristy A.
SCIENCE TRANSLATIONAL MEDICINE, 2023, 15 (684)
[10] Breast and ovarian cancer risk management in a French cohort of 158 women carrying a BRCA1 or BRCA2 germline mutation: patient choices and outcome
This, Pascale
de la Rochefordiere, Anne
Savignoni, Alexia
Falcou, Marie Christine
Tardivon, Anne
Thibault, Fabienne
Alran, Severine
Fourchotte, Virgine
Fitoussi, Alfred
Couturaud, Benoit
Dolbeault, Sylvie
Salmon, Remy J.
Sigal-Zafrani, Brigitte
Asselain, Bernard
Stoppa-Lyonnet, Dominique
FAMILIAL CANCER, 2012, 11 (03) : 473 - 482

← 1 2 3 4 5 →